Pharmacotherapy of Cardiac Arrhythmias-Basic Science for Clinicians (original) (raw)

The arrhythmogenicity of antiarrhythmic agents

David Flowers

American Heart Journal, 1985

View PDFchevron_right

The arrhythmogenicity of antiarrhythmic agents*1

Victor Torres

American Heart Journal, 1985

View PDFchevron_right

Clinical Pharmacology of Antiarrhythmic Drugs

Klaus Romero

Drugs & Aging, 1998

View PDFchevron_right

Arrhythmogenic actions of antiarrhythmic drugs

Andrew Wit

The American Journal of Cardiology, 1987

View PDFchevron_right

Overview of the clinical pharmacology of antiarrhythmic drugs

Alessandro Capucci, Giovanni Villani

The American Journal of Cardiology, 1988

View PDFchevron_right

Feasibility of selection of antiarrhythmic drug treatment on the basis of arrhythmogenic mechanism - Relevance of electrical restitution, wavebreak and rotors

G. André Ng

Pharmacology & therapeutics, 2016

View PDFchevron_right

Clinical pharmacology of antiarrhythmic drugs: Variability of metabolism and dose requirements

Ferenc Follath

Journal of Cardiovascular Pharmacology

View PDFchevron_right

New drugs vs. old concepts: A fresh look at antiarrhythmics

J. Thireau

Pharmacology & Therapeutics, 2011

View PDFchevron_right

USE OF ANTI-ARRHYTHMIC DRUGS IN STABLE TACHYARRHYTHMIA (Atena Editora)

Atena Editora

USE OF ANTI-ARRHYTHMIC DRUGS IN STABLE TACHYARRHYTHMIA (Atena Editora), 2022

View PDFchevron_right

Antiarrhythmic drugs: present and future

Lalit Sharma

The Journal of the Association of Physicians of India, 2007

View PDFchevron_right

Electropharmacology of antiarrhythmic drugs

Andrew Wit

American Heart Journal, 1983

View PDFchevron_right

A Simple In Vivo Model to Evaluate the Effects of Antiarrhythmic Agents

Jean Barbey

Pace-pacing and Clinical Electrophysiology, 1992

View PDFchevron_right

New insights into the definition and meaning of proarrhythmia during initiation of antiarrhythmic drug therapy from the cardiac arrhythmia suppression trial and its pilot study

Robert A Capone G

Journal of the American College of Cardiology, 1994

View PDFchevron_right

The Role of Antiarrhythmic Drug Therapy for the Prevention of Sudden Cardiac Death

Suneeta Mittal

Progress in Cardiovascular Diseases, 2008

View PDFchevron_right

Innovative approaches to anti-arrhythmic drug therapy

Stanley Nattel

Nature Reviews Drug Discovery, 2006

View PDFchevron_right

Electrophysiologic properties and antiarrhythmic actions of a novel antianginal agent

Guillermo Perez

Journal of cardiovascular pharmacology and therapeutics, 2004

View PDFchevron_right

Prolongation of ventricular refractoriness by class Ia antiarrhythmic drugs in the prevention of ventricular tachycardia induction

paolo costi

American Heart Journal, 1990

View PDFchevron_right

Choice and chance in drug therapy of cardiac arrhythmias: Technique versus drug-specific responses in evaluation of efficacy

balbir B singh

The American Journal of Cardiology, 1993

View PDFchevron_right

Comparative hemodynamics of antiarrhythmic drugs

Magdi Sami

Cardiovascular Drugs and Therapy, 1990

View PDFchevron_right

Antiarrhythmic drug therapy: what is certain and what is to come

Alessandro Capucci

European Heart Journal Supplements, 2003

View PDFchevron_right

Electrophysiology and pharmacology of cardiac arrhythmias. II. Relationship of normal and abnormal electrical activity of cardiac fibers to the genesis of arrhythmias B. Re-entry. Section I

Andrew Wit

American Heart Journal, 1974

View PDFchevron_right

Antiarrhythmic drug treatment: need for continuous vigilance

Anton P.m Gorgels

Heart, 1992

View PDFchevron_right

Update on antiarrhythmic drug pharmacology

Christopher Huang

Journal of Cardiovascular Electrophysiology, 2020

View PDFchevron_right

Pro-Arrhythmic Effects of Noncardiac Medications

Sami Viskin

Journal of the American College of Cardiology, 2015

View PDFchevron_right

The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: Clinical and regulatory implications Report on a Policy Conference of the European Society of Cardiology

Charles Antzelevitch

Cardiovascular Research, 2000

View PDFchevron_right

Clinical types of proarrhythmic response to antiarrhythmic drugs

John T. Bigger

The American Journal of Cardiology, 1987

View PDFchevron_right

New method for the assessment of drug-induced arrhythmia aggravation

Karl Wegscheider

The American Journal of Cardiology, 1988

View PDFchevron_right

Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias

Frank Starmer

Circulation, 1990

View PDFchevron_right

Effects of class I antiarrhythmic drugs on the digitalis-induced triggered activity arrhythmia model: a rationale for the short-term use of class I drugs against triggered arrhythmias

Atsushi Sugiyama

Heart and Vessels, 2004

View PDFchevron_right

Clinical Potential of Emerging Antiarrhythmic Agents

Giovanni Villani

Drugs in R & D, 1999

View PDFchevron_right

Antiarrhythmic drug classifications and the clinician: A gambit in the land of chaos

John Camm

Clinical Cardiology, 1994

View PDFchevron_right

Determinants of antiarrhythmic drug efficacy for ventricular tachyarrhythmias using ambulatory monitoring and electrophysiological techniques

Allan Greenspan

Circulation, 1993

View PDFchevron_right

Aggravation of arrhythmia induced with antiarrhythmic drugs during electrophysiologic testing

Federico Lombardi

American Heart Journal, 1985

View PDFchevron_right

Method for evaluating the effects of antiarrhythmic drugs on ventricular tachycardias with different electrophysiologic characteristics and different mechanisms in the infarcted canine heart

Andrew Wit

The American Journal of Cardiology, 1982

View PDFchevron_right